Group One Trading’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.42K Sell
1,000
-2,100
-68% -$13.7K ﹤0.01% 6532
2025
Q4
$19.5K Buy
3,100
+3,000
+3,000% +$17.5K ﹤0.01% 6352
2025
Q3
$390 Buy
+100
New +$410 ﹤0.01% 8173
2024
Q1
Sell
-10
Closed -$95 7519
2023
Q4
$95 Sell
10
-30
-75% -$264 ﹤0.01% 7201
2023
Q3
$476 Buy
40
+10
+33% +$177 ﹤0.01% 7347
2023
Q2
$735 Buy
30
+20
+200% +$521 ﹤0.01% 7319
2023
Q1
$313 Sell
10
-40
-80% -$2.31K ﹤0.01% 6957
2022
Q4
$3.52K Sell
50
-19,650
-100% -$1.46M ﹤0.01% 6480
2022
Q3
$1.7M Sell
19,700
-7,640
-28% -$742K ﹤0.01% 2060
2022
Q2
$2.26M Buy
27,340
+24,790
+972% +$2.19M ﹤0.01% 1944
2022
Q1
$424K Sell
2,550
-1,870
-42% -$268K ﹤0.01% 3999
2021
Q4
$739K Buy
4,420
+4,400
+22,000% +$497K ﹤0.01% 3667
2021
Q3
$2K Sell
20
-110
-85% -$7.28K ﹤0.01% 7940
2021
Q2
$7K Sell
130
-20
-13% -$1.14K ﹤0.01% 7650
2021
Q1
$9K Buy
150
+60
+67% +$3.51K ﹤0.01% 7087
2020
Q4
$5K Hold
90
﹤0.01% 6019
2020
Q3
$4K Buy
90
+10
+13% +$478 ﹤0.01% 5679
2020
Q2
$4K Buy
+80
New +$4.04K ﹤0.01% 5427

Other funds holding KZR

Group One Trading's KZR Position: Q3 2023 in Review

Group One Trading sold out of Kezar Life Sciences (KZR) in Q3 2023, closing a stake of 1,344 shares — an estimated $23.8K sold.

Group One Trading first reported a position in KZR in Q2 2020 and held it in 10 quarters. The position peaked at $763K in Q2 2022. 82 funds tracked by Wall St. Rank hold KZR as of Q3 2023.

  • Group One Trading reported no remaining Kezar Life Sciences position as of Q3 2023 after selling out during the quarter.
  • Group One Trading sold 1,344 Kezar Life Sciences shares in Q3 2023, an estimated $23.8K.
  • Group One Trading first reported a position in Kezar Life Sciences in Q2 2020 and held it in 10 quarters.
  • Group One Trading's Kezar Life Sciences position peaked at $763K in Q2 2022.
  • 82 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2023.

Based on Group One Trading's 13F filing for Q3 2023, filed 9 Nov 2023.